| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |